01 Aug Viridium Retains Renmark Financial Communications Inc. for IR and Integral Wealth Securities Limited for Market Marking
August 1, 2018 — Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: MRRBF) is pleased to announce that it has retained the services of Renmark Financial Communications Inc. (“Renmark”) to handle its investor relations activities.
“We are pleased to have selected Renmark to reinforce Viridium’s profile in the financial community and enhance the visibility of our company. We partnered with Renmark because their standards and methodologies fit best with the message we wish to communicate to the investing public,” noted Jarrett Malnarick, Chief Executive Officer.
For the services to be provided, the monthly fees incurred by Viridium will be a cash consideration of $7,000, starting August 1, 2018 for a period of six months ending on January 31, 2019 and monthly thereafter. Renmark does not have any interest, directly or indirectly, in Viridium or its securities, or any right or intent to acquire such an interest.
Viridium is also pleased to announce that it has retained Integral Wealth Securities Limited (“Integral”) to provide Market-Making services in accordance with TSX Venture Exchange (“TSXV”) policies. Integral will trade securities of Viridium on the TSXV for the purposes of maintaining an orderly market of Viridium’s securities.
In consideration of the services provided by Integral, Viridium will pay Integral a monthly cash fee of $7,000 for a minimum of 12 months with a one-time right to terminate after 6 months, and monthly thereafter. Integral will not receive shares or options as compensation. However, Integral and its clients may have or may acquire a direct interest in the securities of Viridium. Viridium and Integral are unrelated and unaffiliated entities; Integral is a member of the Investment Industry Regulatory Organization of Canada (“IIROC”) and can access all Canadian Stock Exchange and Alternative Trading Systems.
Viridium Pacific Group Ltd. is a consumer wellness and biotech innovation company based in British Columbia, and the parent company of operating subsidiaries involved in horticultural production, (Experion Biotechologies Inc.) property development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.) Experion Biotechnologies Inc., is a Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.
More information about Viridium can be found under the Company’s profile on SEDAR at www.sedar.com.
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.